Similar articles for PMID: 19726418

Year	Number of Results
1983	1
1986	1
1988	1
1995	1
2000	2
2001	3
2002	2
2003	2
2004	7
2005	4
2006	7
2007	6
2008	6
2009	8
2010	10
2011	5
2012	5
2013	4
2014	1
2015	3
2016	5
2017	1
2018	1
2019	3
2020	5
2021	8
2022	1
2023	4
2024	0

1

A randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome.

Jankovic J, Jimenez-Shahed J, Brown LW. Jankovic J, et al. J Neurol Neurosurg Psychiatry. 2010 Jan;81(1):70-3. doi: 10.1136/jnnp.2009.185348. Epub 2009 Sep 1. J Neurol Neurosurg Psychiatry. 2010. PMID: 19726418 Clinical Trial.

2

Baclofen treatment in Tourette syndrome: a double-blind, placebo-controlled, crossover trial.

Singer HS, Wendlandt J, Krieger M, Giuliano J. Singer HS, et al. Neurology. 2001 Mar 13;56(5):599-604. doi: 10.1212/wnl.56.5.599. Neurology. 2001. PMID: 11245709 Clinical Trial.

3

Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial.

Müller-Vahl KR, Schneider U, Prevedel H, Theloe K, Kolbe H, Daldrup T, Emrich HM. Müller-Vahl KR, et al. J Clin Psychiatry. 2003 Apr;64(4):459-65. doi: 10.4088/jcp.v64n0417. J Clin Psychiatry. 2003. PMID: 12716250 Clinical Trial.

4

Topiramate in treatment of tourette syndrome.

Kuo SH, Jimenez-Shahed J. Kuo SH, et al. Clin Neuropharmacol. 2010 Jan-Feb;33(1):32-4. doi: 10.1097/WNF.0b013e3181c295c1. Clin Neuropharmacol. 2010. PMID: 19935407 Free PMC article.

5

Efficacy and Safety of Fixed-Dose Deutetrabenazine in Children and Adolescents for Tics Associated With Tourette Syndrome: A Randomized Clinical Trial.

Coffey B, Jankovic J, Claassen DO, Jimenez-Shahed J, Gertz BJ, Garofalo EA, Stamler DA, Wieman M, Savola JM, Gordon MF, Alexander JK, Barkay H, Harary E. Coffey B, et al. JAMA Netw Open. 2021 Oct 1;4(10):e2129397. doi: 10.1001/jamanetworkopen.2021.29397. JAMA Netw Open. 2021. PMID: 34661664 Free PMC article. Clinical Trial.

6

Efficacy of Glutamate Modulators in Tic Suppression: A Double-Blind, Randomized Control Trial of D-serine and Riluzole in Tourette Syndrome.

Lemmon ME, Grados M, Kline T, Thompson CB, Ali SF, Singer HS. Lemmon ME, et al. Pediatr Neurol. 2015 Jun;52(6):629-34. doi: 10.1016/j.pediatrneurol.2015.02.002. Epub 2015 Feb 19. Pediatr Neurol. 2015. PMID: 26002052 Free PMC article. Clinical Trial.

7

A D1 receptor antagonist, ecopipam, for treatment of tics in Tourette syndrome.

Gilbert DL, Budman CL, Singer HS, Kurlan R, Chipkin RE. Gilbert DL, et al. Clin Neuropharmacol. 2014 Jan-Feb;37(1):26-30. doi: 10.1097/WNF.0000000000000017. Clin Neuropharmacol. 2014. PMID: 24434529 Clinical Trial.

8

N-Acetylcysteine in the Treatment of Pediatric Tourette Syndrome: Randomized, Double-Blind, Placebo-Controlled Add-On Trial.

Bloch MH, Panza KE, Yaffa A, Alvarenga PG, Jakubovski E, Mulqueen JM, Landeros-Weisenberger A, Leckman JF. Bloch MH, et al. J Child Adolesc Psychopharmacol. 2016 May;26(4):327-34. doi: 10.1089/cap.2015.0109. Epub 2016 Mar 30. J Child Adolesc Psychopharmacol. 2016. PMID: 27027204 Free PMC article. Clinical Trial.

9

A double blind randomized placebo control trial of levetiracetam in Tourette syndrome.

Smith-Hicks CL, Bridges DD, Paynter NP, Singer HS. Smith-Hicks CL, et al. Mov Disord. 2007 Sep 15;22(12):1764-70. doi: 10.1002/mds.21615. Mov Disord. 2007. PMID: 17566124 Clinical Trial.

10

The impact of topiramate on health-related quality of life indicators in chronic migraine.

Dodick DW, Silberstein S, Saper J, Freitag FG, Cady RK, Rapoport AM, Mathew NT, Hulihan J, Crivera C, Rupnow MF, Mao L, Finlayson G, Greenberg SJ. Dodick DW, et al. Headache. 2007 Nov-Dec;47(10):1398-408. doi: 10.1111/j.1526-4610.2007.00950.x. Headache. 2007. PMID: 18052949 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

97 results

Results by year